Scobey MJ

No ORCID on file · 1 paper in corpus · active 2005
2005
Subcutaneously administered Menopur, a new highly purified human menopausal gonadotropin, causes significantly fewer injection site reactions than Repronex in subjects undergoing in vitro fertilization.
Reproductive biology and endocrinology : RB&E ·doi:10.1186/1477-7827-3-62

BackgroundThe safety and tolerability of a new highly purified, urine-derived human menopausal gonadotropin (hMG) preparation [Menopur] was compared with a currently available hMG [Repronex] in women undergoing in vitro fertilization (IVF).…